Table 1

ODSH has only minimal anticoagulant activity

aPTT, s
Anti-Xa UFH, IU/mL
+Buffer+2 μg/mL UFH+Buffer+2 μg/mL UFH
+Buffer 31.7 49.0 0.00 0.10 
+1 μg/mL ODSH 31.1 48.0 0.04 0.11 
+2 μg/mL ODSH 33.1 48.4 0.02 0.11 
+4 μg/mL ODSH 33.0 51.5 0.02 0.11 
+8 μg/mL ODSH 35.8 55.8 0.02 0.13 
+16 μg/mL ODSH 41.6 64.7 0.04 0.14 
aPTT, s
Anti-Xa UFH, IU/mL
+Buffer+2 μg/mL UFH+Buffer+2 μg/mL UFH
+Buffer 31.7 49.0 0.00 0.10 
+1 μg/mL ODSH 31.1 48.0 0.04 0.11 
+2 μg/mL ODSH 33.1 48.4 0.02 0.11 
+4 μg/mL ODSH 33.0 51.5 0.02 0.11 
+8 μg/mL ODSH 35.8 55.8 0.02 0.13 
+16 μg/mL ODSH 41.6 64.7 0.04 0.14 

ODSH indicates 2-O, 3-O desulfated heparin; aPTT, activated thromboplastin time; and UFH, unfractionated heparin.

aPTT and anti-Xa activity in pooled plasma (n = 25) was analyzed in the presence of buffer (0.9% saline; baseline activity), or 2 μg/mL (∼ 0.3 IU/mL) UFH alone (line 1). Then increasing concentrations of ODSH were added. Up to a concentration of 4 μg/mL, ODSH had only minimal effects on the aPTT or anti-Xa activity.